DNMT3A in haematological malignancies (original) (raw)

• Peters, S. L. et al. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas. Mol. Cell. Biol. 33, 4321–4333 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Laird, P. W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197–205 (1995).
  Article CAS PubMed Google Scholar
• Broske, A. M. et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nature Genet. 41, 1207–1215 (2009).
  Article CAS PubMed Google Scholar
• Kim, M. S., Kim, Y. R., Yoo, N. J. & Lee, S. H. Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers. Apmis 121, 85–94 (2013).
  Article CAS PubMed Google Scholar
• Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333–339 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Forbes, S. A. et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945–D950 (2011).
  Article CAS PubMed Google Scholar
• Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
  Article CAS PubMed Google Scholar
• Holliday, R. & Grigg, G. W. DNA methylation and mutation. Mutat. Res. 285, 61–67 (1993).
  Article CAS PubMed Google Scholar
• You, J. S. & Jones, P. A. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22, 9–20 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Galm, O., Herman, J. G. & Baylin, S. B. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev. 20, 1–13 (2006).
  Article CAS PubMed Google Scholar
• Weisenberger, D. J. et al. Identification and characterization of alternatively spliced variants of DNA methyltransferase 3a in mammalian cells. Gene 298, 91–99 (2002).
  Article CAS PubMed Google Scholar
• Schoofs, T. & Müller-Tidow, C. DNA methylation as a pathogenic event and as a therapeutic target in AML. Cancer Treat. Rev. 37 (Suppl. 1), 1–6 (2011).
  Google Scholar
• Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nature Genet. 43, 768–775 (2011).
  Article CAS PubMed Google Scholar
• Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nature Genet. 19, 219–220 (1998).
  Article CAS PubMed Google Scholar
• Wienholz, B. L. et al. DNMT3L modulates significant and distinct flanking sequence preference for DNA methylation by DNMT3A and DNMT3B in vivo. PLoS Genet. 6, e1001106 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kaneda, M. et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429, 900–903 (2004).
  Article CAS PubMed Google Scholar
• Cedar, H. & Bergman, Y. Epigenetics of haematopoietic cell development. Nature Rev. Immunol. 11, 478–488 (2011).
  Article CAS Google Scholar
• Subramaniam, D., Thombre, R., Dhar, A. & Anant, S. DNA methyltransferases: a novel target for prevention and therapy. Front. Oncol. 4, 80 (2014).
  Article PubMed PubMed Central Google Scholar
• Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930–935 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pastor, W. A. et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473, 394–397 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Inoue, A. & Zhang, Y. Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 334, 194 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Robertson, K. D. et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27, 2291–2298 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Xie, S. et al. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 236, 87–95 (1999).
  Article CAS PubMed Google Scholar
• Chen, T., Ueda, Y., Xie, S. & Li, E. A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J. Biol. Chem. 277, 38746–38754 (2002).
  Article CAS PubMed Google Scholar
• Tadokoro, Y., Ema, H., Okano, M., Li, E. & Nakauchi, H. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J. Exp. Med. 204, 715–722 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Yanagisawa, Y., Ito, E., Yuasa, Y. & Maruyama, K. The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. Biochim. Biophys. Acta 1577, 457–465 (2002).
  Article CAS PubMed Google Scholar
• Suetake, I. et al. Characterization of DNA-binding activity in the N-terminal domain of the DNA methyltransferase Dnmt3a. Biochem. J. 437, 141–148 (2011).
  Article CAS PubMed Google Scholar
• Dhayalan, A. et al. The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J. Biol. Chem. 285, 26114–26120 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fuks, F., Burgers, W. A., Godin, N., Kasai, M. & Kouzarides, T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20, 2536–2544 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Otani, J. et al. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep. 10, 1235–1241 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Y. et al. Chromatin methylation activity of Dnmt3a and Dnmt3a/3L is guided by interaction of the ADD domain with the histone H3 tail. Nucleic Acids Res. 38, 4246–4253 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Guo, X. et al. Structural insight into autoinhibition and histone H3-induced activation of DNMT3A. Nature http://dx.doi.org/10.1038/nature13899 (2014). References 30 and 32 demonstrate that the auto-inhibitory function of the ADD domain of DNMT3A provides the link between H3K4 methylation and DNMT3A.
• Xu, F. et al. Molecular and enzymatic profiles of mammalian DNA methyltransferases: structures and targets for drugs. Curr. Med. Chem. 17, 4052–4071 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Jia, D., Jurkowska, R. Z., Zhang, X., Jeltsch, A. & Cheng, X. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 449, 248–251 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Holz-Schietinger, C. & Reich, N. O. The inherent processivity of the human de novo methyltransferase 3A (DNMT3A) is enhanced by DNMT3L. J. Biol. Chem. 285, 29091–29100 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, T., Ueda, Y., Dodge, J. E., Wang, Z. & Li, E. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23, 5594–5605 (2003). This article deeply explores the phenotype in ESCs of ablation of Dnmt3a and Dnmt3b , establishing the paradigm of extended self-renewal and DNA methylation loss, foreshadowing the somatic stem cell phenotype.
  Article CAS PubMed PubMed Central Google Scholar
• Ostler, K. R. et al. Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene 26, 5553–5563 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Gordon, C. A., Hartono, S. R. & Chedin, F. Inactive DNMT3B splice variants modulate de novo DNA methylation. PLoS ONE 8, e69486 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bachman, K. E., Rountree, M. R. & Baylin, S. B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276, 32282–32287 (2001).
  Article CAS PubMed Google Scholar
• Chen, T., Tsujimoto, N. & Li, E. The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin. Mol. Cell. Biol. 24, 9048–9058 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hattori, N. et al. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells. Genome Res. 14, 1733–1740 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Choi, S. H. et al. Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Res. 39, 104–118 (2011).
  Article CAS PubMed Google Scholar
• Robertson, A. K., Geiman, T. M., Sankpal, U. T., Hager, G. L. & Robertson, K. D. Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro. Biochem. Biophys. Res. Commun. 322, 110–118 (2004).
  Article CAS PubMed Google Scholar
• Takeshima, H. et al. Distinct DNA methylation activity of Dnmt3a and Dnmt3b towards naked and nucleosomal DNA. J. Biochem. 139, 503–515 (2006).
  Article CAS PubMed Google Scholar
• Yang, Y. et al. CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing. Oncogene 34, 104–118 (2013).
  Article CAS PubMed Google Scholar
• Weissmann, F. et al. DNA hypermethylation in Drosophila melanogaster causes irregular chromosome condensation and dysregulation of epigenetic histone modifications. Mol. Cell. Biol. 23, 2577–2586 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Fuks, F., Hurd, P. J., Deplus, R. & Kouzarides, T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 31, 2305–2312 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Muramatsu, D., Singh, P. B., Kimura, H., Tachibana, M. & Shinkai, Y. Pericentric heterochromatin generated by HP1 protein interaction-defective histone methyltransferase Suv39h1. J. Biol. Chem. 288, 25285–25296 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Karimi, M. M. et al. DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 8, 676–687 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Epsztejn-Litman, S. et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nature Struct. Mol. Biol. 15, 1176–1183 (2008).
  Article CAS Google Scholar
• Chang, Y. et al. MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a. Nature Commun. 2, 533 (2011).
  Article CAS Google Scholar
• Rush, M. et al. Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation. Epigenetics 4, 404–414 (2009).
  Article CAS PubMed Google Scholar
• Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871–874 (2006).
  Article CAS PubMed Google Scholar
• Jeong, M. et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nature Genet. 46, 17–23 (2014). This paper defines 'DNA methylation canyons', which are large, under-methylated regions of the genome that are particularly affected by the loss of DNMT3A. It is also suggested that TET proteins and histone marks interplay at canyons.
  Article CAS PubMed Google Scholar
• Xie, W. et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell 153, 1134–1148 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, H. et al. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 329, 444–448 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Meissner, A. et al. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 33, 5868–5877 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, I. G., Han, L., Taghva, A., O'Brien, L. E. & Hsieh, C. L. Murine de novo methyltransferase Dnmt3a demonstrates strand asymmetry and site preference in the methylation of DNA in vitro. Mol. Cell. Biol. 22, 704–723 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Handa, V. & Jeltsch, A. Profound flanking sequence preference of Dnmt3a and Dnmt3b mammalian DNA methyltransferases shape the human epigenome. J. Mol. Biol. 348, 1103–1112 (2005).
  Article CAS PubMed Google Scholar
• Gowher, H. et al. Mutational analysis of the catalytic domain of the murine Dnmt3a DNA-(cytosine C5)-methyltransferase. J. Mol. Biol. 357, 928–941 (2006). This paper describes a mutational analysis that reveals the key role of specific residues in the catalytic domain of DNMT3A.
  Article CAS PubMed Google Scholar
• Suetake, I., Miyazaki, J., Murakami, C., Takeshima, H. & Tajima, S. Distinct enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and Dnmt3b. J. Biochem. 133, 737–744 (2003).
  Article CAS PubMed Google Scholar
• Gowher, H. & Jeltsch, A. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites. J. Mol. Biol. 309, 1201–1208 (2001).
  Article CAS PubMed Google Scholar
• Ramsahoye, B. H. et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl Acad. Sci. USA 97, 5237–5242 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766–770 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lister, R. et al. Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Guo, J. U. et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nature Neurosci. 17, 215–222 (2014).
  Article CAS PubMed Google Scholar
• Ziller, M. J. et al. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet. 7, e1002389 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257 (1999).
  Article CAS PubMed Google Scholar
• Schmidt, C. S. et al. Global DNA hypomethylation prevents consolidation of differentiation programs and allows reversion to the embryonic stem cell state. PLoS ONE 7, e52629 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Challen, G. A. et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nature Genet. 44, 23–31 (2012). This article shows that ablation of Dnmt3a in HSCs leads to stem cell expansion and inhibited differentiation, providing the conceptual framework for understanding the role of DNMT3A mutations in human haematological malignancies.
  Article CAS Google Scholar
• Challen, G. A. et al. Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell 15, 350–364 (2014). This article shows the roles of DNMT3B and DNMT3A in HSC differentiation, implicating the β-catenin pathway, upregulation of self-renewal genes and attendant epigenetic changes in the molecular and cellular phenotype.
  Article CAS PubMed PubMed Central Google Scholar
• Hao, J., Li, T. G., Qi, X., Zhao, D. F. & Zhao, G. Q. WNT/β-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev. Biol. 290, 81–91 (2006).
  Article CAS PubMed Google Scholar
• Wu, Z. et al. Dnmt3a regulates both proliferation and differentiation of mouse neural stem cells. J. Neurosci. Res. 90, 1883–1891 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Tatton-Brown, K. et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nature Genet. 46, 385–388 (2014).
  Article CAS PubMed Google Scholar
• Yamashita, Y. et al. Array-based genomic resequencing of human leukemia. Oncogene 29, 3723–3731 (2010).
  Article CAS PubMed Google Scholar
• Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424–2433 (2010). This seminal paper reports the frequency and clinical significance of DNMT3A mutations in a large cohort of patients with acute myeloid leukaemia.
  Article CAS PubMed PubMed Central Google Scholar
• Yan, X. J. et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genet. 43, 309–315 (2011).
  Article CAS PubMed Google Scholar
• The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059–2074 (2013). This work is a comprehensive genetic and epigenetic analysis of patients with AML that provides a valuable database of patients with DNMT3A and other commonly occurring mutations.
• Huether, R. et al. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nature Commun. 5, 3630 (2014).
  Article CAS Google Scholar
• Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506–510 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264–278 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Shlush, L. I. et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506, 328–333 (2014). This study identifies DNMT3A mut HSCs as the pre-leukaemic founding clones in AML.
  Article CAS PubMed PubMed Central Google Scholar
• Corces-Zimmerman, M. R., Hong, W. J., Weissman, I. L., Medeiros, B. C. & Majeti, R. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc. Natl Acad. Sci. USA 111, 2548–2553 (2014). This study demonstrates the existence of pre-leukaemic HSCs in AML and at remission, and the predominance of mutations in epigenetic modifiers, including DNMT3A.
  Article CAS PubMed PubMed Central Google Scholar
• Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nature Med. 20, 1472–1478 (2014).
  Article CAS PubMed Google Scholar
• Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477–2487 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488–2498 (2014). References 84, 85 and 86 demonstrate the striking age-related increase of clonal haematopoiesis and highlight DNMT3A mutations as being highly correlated with this state.
  Article CAS PubMed PubMed Central Google Scholar
• Mayle, A. et al. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood 125, 629–638 (2014).
  Article CAS Google Scholar
• Celik, H. et al. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. Blood 125, 619–628 (2014). References 87 and 88 show that ablation (knockout) of Dnmt3a in mouse stem cells can recapitulate the range of haematological malignancies seen in patients, despite the distinct genetic lesions observed in such malignancies.
  Article CAS Google Scholar
• Patel, J. P. et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N. Engl. J. Med. 366, 1079–1089 (2012). This study reports the frequency and prognostic relevance of DNMT3A mutations and other recurrent mutations in a large, uniformly treated cohort of adults with AML.
  Article CAS PubMed PubMed Central Google Scholar
• Shen, Y. et al. Gene mutation patterns and their prognostic impact in a cohort of 1,185 patients with acute myeloid leukemia. Blood 118, 5593–5603 (2011).
  Article CAS PubMed Google Scholar
• Ribeiro, A. F. T. et al. Mutant DNMT3A: a new marker of poor prognosis in acute myeloid leukemia. Blood 119, 5824–5831 (2012).
  Article CAS PubMed Google Scholar
• Gaidzik, V. I. et al. Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). Blood 121, 4769–4777 (2013).
  Article CAS PubMed Google Scholar
• Hou, H. A. et al. Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia. Leukemia 28, 50–58 (2014).
  Article CAS PubMed Google Scholar
• Hou, Y. et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148, 873–885 (2012).
  Article CAS PubMed Google Scholar
• Bejar, R. et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J. Clin. Oncol. 30, 3376–3382 (2012).
  Article PubMed PubMed Central Google Scholar
• Roller, A. et al. Landmark analysis of DNMT3A mutations in hematological malignancies. Leukemia 27, 1573–1578 (2013).
  Article CAS PubMed Google Scholar
• Walter, M. J. et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 25, 1153–1158 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Stegelmann, F. et al. DNMT3A mutations in myeloproliferative neoplasms. Leukemia 25, 1217–1219 (2011).
  Article CAS PubMed Google Scholar
• Abdel-Wahab, O. et al. DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms. Leukemia 25, 1219–1220 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Jankowska, A. M. et al. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood 118, 3932–3941 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Odejide, O. et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123, 1293–1296 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Palomero, T. et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nature Genet. 46, 166–170 (2014).
  Article CAS PubMed Google Scholar
• Sakata-Yanagimoto, M. et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nature Genet. 46, 171–175 (2014). References 101–103 demonstrate the high frequency of DNMT3A mutations and their striking association with IDH and TET2 mutations in peripheral T cell lymphomas.
  Article CAS PubMed Google Scholar
• Grossmann, V. et al. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes Chromosomes Cancer 52, 410–422 (2013).
  Article CAS PubMed Google Scholar
• Holz-Schietinger, C., Matje, D. M. & Reich, N. O. Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation. J. Biol. Chem. 287, 30941–30951 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Holz-Schietinger, C., Matje, D. M., Harrison, M. F. & Reich, N. O. Oligomerization of DNMT3A controls the mechanism of de novo DNA methylation. J. Biol. Chem. 286, 41479–41488 (2011). References 105 and 106 show the crucial role of DNMT3A oligomerization in maintaining high DNA methylation activity in addition to the mechanistic effect of specific AML-associated mutations.
  Article CAS PubMed PubMed Central Google Scholar
• Kim, S. J. et al. A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood 122, 4086–4089 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Russler-Germain, D. A. et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell 25, 442–454 (2014). References 107 and 108 provide insights into the common DNMT3A R882 mutation, showing that it can act as a dominant-negative mutationin mouse ESCs and human AML cells.
  Article CAS PubMed PubMed Central Google Scholar
• Qu, Y. et al. Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes. Epigenetics 9, 1108–1119 (2014).
  Article PubMed PubMed Central Google Scholar
• Raddatz, G., Gao, Q., Bender, S., Jaenisch, R. & Lyko, F. Dnmt3a protects active chromosome domains against cancer-associated hypomethylation. PLoS Genet. 8, e1003146 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ziller, M. J. et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 500, 477–481 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Stadler, M. B. et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480, 490–495 (2011).
  Article CAS PubMed Google Scholar
• Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376–380 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ho, P. A. et al. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group. Pediatr. Blood Cancer 57, 204–209 (2011).
  Article PubMed PubMed Central Google Scholar
• Hollink, I. H. I. M. et al. Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model. 26, 371–373 (2011).
• Liang, D. C. et al. Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A. Blood 121, 2988–2995 (2013).
  Article CAS PubMed Google Scholar
• Shiba, N. et al. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia. Br. J. Haematol. 156, 413–414 (2012).
  Article CAS PubMed Google Scholar
• Thol, F. et al. DNMT3A mutations are rare in childhood acute myeloid leukemia. Haematologica 96, 1238–1240 (2011).
  Article PubMed PubMed Central Google Scholar
• Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157–163 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Figueroa, M. E. et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 17, 13–27 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Haferlach, T. et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28, 241–247 (2014).
  Article CAS PubMed Google Scholar
• Damm, F. et al. Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood 119, 3211–3218 (2012).
  Article CAS PubMed Google Scholar
• Marcucci, G. et al. Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J. Clin. Oncol. 30, 742–750 (2012).
  Article PubMed PubMed Central Google Scholar
• Renneville, A. et al. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia 26, 1247–1254 (2012).
  Article CAS PubMed Google Scholar
• Hajkova, H. et al. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation. Leuk. Res. 36, 1128–1133 (2012).
  Article CAS PubMed Google Scholar
• Fried, I. et al. Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia. Haematologica 97, 246–250 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Zebisch, A., Hoefler, G., Quehenberger, F., Wolfler, A. & Sill, H. Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability? Leukemia 27, 1777–1778 (2013).
  Article CAS PubMed Google Scholar
• Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474–478 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Thol, F. et al. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 119, 3578–3584 (2012).
  Article CAS PubMed Google Scholar
• Thol, F. et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J. Clin. Oncol. 29, 2889–2896 (2011).
  Article CAS PubMed Google Scholar
• Thol, F. et al. Rare occurence of DNMT3A mutations in myelodysplastic syndromes. Haematologica 96, 1870–1873 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, C. C. et al. IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. Am. J. Hematol. 89, 137–144 (2014).
  Article CAS PubMed Google Scholar
• Fried, I. et al. Mutations in DNMT3A and loss of RKIP are independent events in acute monocytic leukemia. Haematologica 97, 1936–1937 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kar, S. A. et al. Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Haematologica 98, 107–113 (2012).
  Article CAS PubMed Google Scholar
• Quintas-Cardama, A. et al. Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a. Blood 122, 893–901 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Van Vlierberghe, P. et al. Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia. Blood 122, 74–82 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Neumann, M. et al. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood 121, 4749–4752 (2013).
  Article CAS PubMed Google Scholar
• LaRochelle, O. et al. Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience. Oncotarget 2, 850–861 (2011).
  Article PubMed PubMed Central Google Scholar
• Herman, J. G. et al. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 57, 837–841 (1997).
  CAS PubMed Google Scholar
• Paul, T. A., Bies, J., Small, D. & Wolff, L. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. Blood 115, 3098–3108 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Toyota, M. et al. Methylation profiling in acute myeloid leukemia. Blood 97, 2823–2829 (2001).
  Article CAS PubMed Google Scholar
• Traina, F. et al. Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia 28, 78–87 (2014).
  Article CAS PubMed Google Scholar
• Klco, J. M. et al. Genomic impact of transient low-dose decitabine treatment on primary AML cells. Blood 121, 1633–1643 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ostronoff, F. et al. Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report. Leukemia 27, 238–241 (2013).
  Article CAS PubMed Google Scholar
• Ross, D. M. et al. Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia 24, 1719–1724 (2010).
  Article CAS PubMed Google Scholar
• Busque, L. et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nature Genet. 44, 1179–1181 (2012).
  Article CAS PubMed Google Scholar
• Couronne, L., Bastard, C. & Bernard, O. A. TET2 and DNMT3A mutations in human T-cell lymphoma. N. Engl. J. Med. 366, 95–96 (2012).
  Article CAS PubMed Google Scholar
• Brown, S. J., Stoilov, P. & Xing, Y. Chromatin and epigenetic regulation of pre-mRNA processing. Hum. Mol. Genet. 21, R90–R96 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R. & Misteli, T. Epigenetics in alternative pre-mRNA splicing. Cell 144, 16–26 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zemach, A., McDaniel, I. E., Silva, P. & Zilberman, D. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 328, 916–919 (2010).
  Article CAS PubMed Google Scholar
• Kolasinska-Zwierz, P. et al. Differential chromatin marking of introns and expressed exons by H3K36me3. Nature Genet. 41, 376–381 (2009).
  Article CAS PubMed Google Scholar
• Laurent, L. et al. Dynamic changes in the human methylome during differentiation. Genome Res. 20, 320–331 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Regulski, M. et al. The maize methylome influences mRNA splice sites and reveals widespread paramutation-like switches guided by small RNA. Genome Res. 23, 1651–1662 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshida, K. et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64–69 (2011).
  Article CAS PubMed Google Scholar
• Jurkowska, R. Z., Jurkowski, T. P. & Jeltsch, A. Structure and function of mammalian DNA methyltransferases. Chembiochem 12, 206–222 (2011).
  Article CAS PubMed Google Scholar
• Purdy, M. M., Holz-Schietinger, C. & Reich, N. O. Identification of a second DNA binding site in human DNA methyltransferase 3A by substrate inhibition and domain deletion. Arch. Biochem. Biophys. 498, 13–22 (2010).
  Article CAS PubMed Google Scholar
• Kotini, A. G., Mpakali, A. & Agalioti, T. Dnmt3a1 upregulates transcription of distinct genes and targets chromosomal gene clusters for epigenetic silencing in mouse embryonic stem cells. Mol. Cell. Biol. 31, 1577–1592 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ge, Y. Z. et al. Chromatin targeting of de novo DNA methyltransferases by the PWWP domain. J. Biol. Chem. 279, 25447–25454 (2004).
  Article CAS PubMed Google Scholar
• Li, B. Z. et al. Histone tails regulate DNA methylation by allosterically activating de novo methyltransferase. Cell Res. 21, 1172–1181 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401–404 (2012).
  Article PubMed Google Scholar
• Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Traina, F. et al. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PLoS ONE 7, e43090 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, J. et al. Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS ONE 6, e26906 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Itzykson, R., Kosmider, O. & Fenaux, P. Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes. Best Pract. Res. Clin. Haematol. 26, 355–364 (2013).
  Article CAS PubMed Google Scholar
• Wlodarski, M. W. et al. Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A. Blood 118, 4490–4491 (2011).
  Article CAS PubMed Google Scholar
• Kern, W. et al. Mixed phenotype acute leukemia, T/myeloid, NOS (MPAL-TM) has a high DNMT3A mutation frequency and carries further genetic features of both AML and T-ALL: results of a comprehensive next-generation sequencing study analyzing 32 genes. Blood 120, 403 (2012).
  Google Scholar
• Rajavelu, A., Jurkowska, R. Z., Fritz, J. & Jeltsch, A. Function and disruption of DNA methyltransferase 3a cooperative DNA binding and nucleoprotein filament formation. Nucleic Acids Res. 40, 569–580 (2012).
  Article CAS PubMed Google Scholar